Tvardi Therapeutics (TVRD) Misses Q4 EPS by 78c
Tweet
Share
E-mailGet Alerts TVRD Hot Sheet
Join SI Premium – FREE
Tvardi Therapeutics (NASDAQ: TVRD) reported Q4 EPS of ($0.78).
For earnings history and earnings-related data on Tvardi Therapeutics (TVRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Visa deposits $405M into U.S. litigation escrow, adjusting stock rates
- H.B. Fuller (FUL) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
